Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Thermo Fisher Scientific to spend $600M to boost bioprocessing production capabilities

By Chris Newmarker | March 10, 2021

Thermo Fisher ScientificThermo Fisher Scientific (NYSE:TMO) will spend more than $600 million to expand its bioprocessing production capabilities through 2022, the Waltham, Mass.–based company said today.

Investments will more than double Thermo Fisher’s manufacturing capacity so that it can better support biopharma customers ramping up to meet not only short-term demands related to COVID-19 but also long-term efforts to develop new vaccines and biologics for other conditions. The company expects the expansion to create more than 1,500 new jobs across 11 manufacturing sites in the Americas, Europe and Asia.

“As the bioprocessing market grows, our customers require a consistent and reliable supply of critical materials. Single-use technologies, cell culture media and purification resins are among those in highest demand,” Thermo Fisher Scientific EVP Michel Lagarde said in a news release.

“These investments add significant capacity and regional redundancy to further bolster supply chains and help us better support customers as they accelerate the commercialization of lifesaving therapies and vaccines,” Lagarde said.

Investments include:

  • Thermo Fisher’s single-use technologies business will increase its supply chain resiliency by expanding capacity at sites in Logan, Utah; Millersburg, Pa.; Cramlington, U.K.; Singapore and Suzhou, China — with additional investment at its Santa Clara, Calif. location to expand bioprocessing equipment and automation capacity.
  • Thermo Fisher will also expand its POROS resin manufacturing site in Bedford, Mass. and open a new 85,000-square-foot manufacturing facility in Chelmsford, Mass. .
  • Expanded capacity at sites in Grand Island, N.Y.; Miami, Fla. and Inchinnan, Scotland will boost production of Gibco cell culture media, supplements and process liquids — as well as the manufacturing of customer-owned proprietary media formulations. The investments provide redundancy to support global supply and further extend capabilities, including harmonizing dual-milling options worldwide.

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE